Insulet (NSDQ:PODD) said today that it inked a deal with Mode Automated Glucose Control to develop an artificial pancreas using its flagship OmniPod device. The deal would see the Mode AGC algorithm incorporated into the OmniPod glucose management system, the Billerica, Mass.-based company said. The algorithm, co-developed by Insulet medical director Dr. Howard Zisser, Francis Doyle and […]